WBDR 2018 Data Report
The World Bleeding Disorders Registry (WBDR) 2018 Data Report provides aggregate data on more than 1100 people with hemophilia around the globe who are registered in the WBDR.
Annual Global Survey Mini Report 2: Age
The WFH Annual Global Survey (AGS) mini reports are advocacy tools that provide more in-depth perspective and context to AGS data. The second Mini Report, based on 2017 AGS data, highlights the age of patients with hemophilia. Age data can be an important tool to better understand diagnosis and treatment in a country.
Recommendations for management of pregnancy and delivery in women with inherited bleeding disorders
In the Sunday morning session entitled Women and Bleeding Disorders, Sue Pavord talks about the UK Guidelines for the management of inherited bleeding disorders in pregnancy and gives an overview of the recommendations included for hemophilia, von Willebrand Disease, rare factor deficiencies, and platelet function disorders.
Chromogenic Factor IX Assay in Laboratory Diagnosis and Monitoring of Treatment in Hemophilia B – To be aware of Challenges
In the Tuesday afternoon session entitled Chromogenic Factor IX Assay in Laboratory Diagnosis and Monitoring of Treatment in Hemophilia B – To be Aware of Challenges, Jovan Antovic presents data comparing one-stage assays with chromogenic assays for quantifying clotting factor activity, focusing on the challenges presented by their use in diagnosis.
New Biological Insights in von Willebrand Disease: Angiogenesis and Angiodysplasia
In the Tuesday afternoon session entitled von Willebrand Disease: Clinical Conundrums, Anna Randi describes the mechanisms that regulate angiogenesis proposing a possible role of VWF in this regulation and discussing therapeutic implications of the latest findings in this field.
von Willebrand Disease: Current Approaches to Diagnosis and Treatment
In the Tuesday afternoon session entitled von Willebrand Disease: Clinical Conundrums, Frank Leebek presents the current challenges in VWD diagnosis and treatment, namely bleeding score variability, overlap of type 1 VWD with low VWF, and the hampering effect of biological variation on test results, as well as the effect of DDAVP on VWF levels.
Investigational SPK-9001: AAV-Mediated Gene Transfer for Hemophilia B – Persistent, Stable Factor IX Activity at One Year Independent of Downstream Purification Method
In the Tuesday morning session entitled Free Papers – Gene Therapy, Spencer Sullivan presents clinical results of FIX gene transfer using in vivo recombinant AAV delivery with the novel bioengineered vector SPA-9001, discussing vector design, FIX activity attained, and safety.
New Approaches to Tolerance: Oral Delivery of Blood Clotting Factors Bioencapsulated in Plant Cells
In the Monday morning session entitled Inhibitors: Clinical Aspects, Henry Daniell presents current advances in the development of new, affordable systems for oral delivery of clotting factors.
ePosters of the XXXIII International Congress of the World Federation of Hemophilia
This interactive carousel features over 350 posters presented at the WFH 2018 World Congress, which can be searched by title, author, poster number, or topic. Via the Options tab on the right, viewers may download, print, or email posters; email poster authors directly; or participate in an online discussion. Presentation slides can also be viewed […]
What is… Health Economics and Health Economic Evaluation
In the Wednesday morning session entitled Can’t or Won’t Pay: Health Economics and Bleeding Disorders, Jamie O’Hara describes the many variables and types of analyses that go into health economics assessments.
How to Set Up Chromogenic FVIII and FIX Assays
In the Tuesday afternoon session entitled Role of Chromogenic Assays in Hemophilia Diagnosis, Annette Bowyer explains how to set up chromogenic assays for FVIII and FIX, covering technical aspects such as calibration, accuracy, and quality control in the context of these assays, as well as the cost implications of using them appropriately.
Role of Chromogenic FVIII Assays in Hemophilia A Diagnosis
In the Tuesday afternoon session entitled Role of Chromogenic Assays in Hemophilia Diagnosis, Elizabeth Duncan presented a comparison of clotting assays versus the chromogenic assay in quantifying FVIII, highlighting genotype and phenotype discrepancies and reverse discrepancies.